Two implanted heart devices used by patients in end-stage heart failure are now under a strict U.S. Food and Drug ...
Two medical devices that mechanically pump blood to the heart have caused hundreds of injuries and more than a dozen deaths ...
The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's device used to block blood flow ...
The Food and Drug Administration (FDA) recently announced that two heart devices, the HeartMate II and HeartMate 3 Left ...
People should rely on the well-established Heimlich maneuver to save a choking victim, rather than newfangled "anti-choking" ...
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of ...
Obsidio Embolic is an FDA cleared, single-use product indicated for the minimally invasive embolization of hypervascular ...
New Jersey native Lisa Pisano has gotten a new lease on life, thanks to a combined transplant of a mechanical heart pump and ...
Biological material can build up and obstruct blood flow in heart failure patients supported by the left ventricular assist devices, the FDA said.
Stifel Nicolaus analyst Rick Wise has maintained their bullish stance on BSX stock, giving a Buy rating today. Rick Wise’s rating is based on a comprehensive evaluation of Boston Scientific’s recent ...
The Implantable Infusion Pumps Market Size is valued at USD16.24 Billion in 2023 and is predicted to reach USD 23.96 Billion by the year 2031 at a 5.15 % CAGR during the forecast ...
The recall affects the only medical option for many patients with end-stage heart failure who do not qualify for a transplant ...